Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
8 hedge funds and large institutions have $816K invested in Biostar Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
2% less capital invested
Capital invested by funds: $836K → $816K (-$20K)
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$75.1K |
| 2 |
Renaissance Technologies
New York
|
+$60.1K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$1.58K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$439 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $707K | +$60.1K | +6,714 | +7% |
|
|
NCCM
2
Nine Chapters Capital Management
Short Hills,
New Jersey
| $61K | +$75.1K | +8,386 | New |
|
3
California Public Employees Retirement System
Sacramento,
California
| $15K | – | – | – |
|
|
ISB
4
Iowa State Bank
Urbandale,
Iowa
| $13K | – | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| $13K | +$1.58K | +177 | +11% |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | +$439 | +49 | +6% |
|
7
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$12K | -1,468 | Closed |
|
BSPM Hedge Fund Activity: Q2 2015 in Review
8 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q2 2015, worth a combined $816K — down 2.4% from $836K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BSPM and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was Nine Chapters Capital Management, opening a new position worth an estimated $75.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $12K sold.
- 8 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q2 2015, down from 9 in Q1 2015.
- Funds reported $816K of Biostar Pharmaceuticals, Inc. stock for Q2 2015, down 2.4% quarter-over-quarter.
- 1 fund opened new Biostar Pharmaceuticals, Inc. positions in Q2 2015 and 2 closed out, a net change of -1 holder.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q2 2015 was Nine Chapters Capital Management, an estimated $75.1K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q2 2015 was Citadel Advisors, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2015.